Valuation: Check-Cap

Market Cap 8.24M 7.22M 6.67M 6.16M 11.68M 789M 11.91M 80.17M 31.15M 386M 30.93M 30.25M 1.34B P/E 2024
-0.23x
P/E 2025 2.44x
Enterprise Value 8.03M 7.05M 6.5M 6.01M 11.39M 769M 11.62M 78.2M 30.38M 376M 30.17M 29.5M 1.31B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
-
Yield 2024 *
-
Yield 2025 -
1 day-0.88%
1 week-8.87%
Current month-9.60%
1 month-23.65%
3 months-31.10%
6 months-35.43%
Current year-30.25%
1 week 1.09
Extreme 1.0901
1.18
1 month 1.06
Extreme 1.0566
1.47
Current year 1.06
Extreme 1.0566
3.92
1 year 0.59
Extreme 0.593
3.92
3 years 0.56
Extreme 0.56
4.62
5 years 0.56
Extreme 0.56
26.2
10 years 0.56
Extreme 0.56
820.8
Manager TitleAgeSince
Chief Executive Officer 45 16/07/2024
Director of Finance/CFO 51 05/04/2025
Human Resources Officer - 31/12/2008
Director TitleAgeSince
Director/Board Member 53 24/01/2024
Chairman 45 24/01/2024
Director/Board Member 54 24/01/2024

Financials

2024 2025
Net sales - -
Net income -25.15M -22.06M -20.36M -18.82M -35.67M -2.41B -36.38M -245M -95.12M -1.18B -94.44M -92.37M -4.09B 4.14M 3.63M 3.35M 3.1M 5.87M 396M 5.99M 40.3M 15.66M 194M 15.55M 15.21M 673M
Net Debt -129K -113K -104K -96.53K -183K -12.35M -187K -1.26M -488K -6.04M -484K -474K -20.98M -203K -178K -164K -152K -288K -19.44M -294K -1.98M -768K -9.51M -762K -746K -33.02M
Logo Check-Cap
Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
Employees
85
Sector
-
Date Price Change Volume
08/07/26 US$1.130 -0.88% 13,635
07/07/26 US$1.140 -1.72% 31,772
06/07/26 US$1.160 +1.75% 18,764
02/07/26 US$1.140 -8.06% 51,735
01/07/26 US$1.240 -0.80% 20,155
  1. Stock Market
  2. Stocks
  3. MBAI Stock